Curis | CRIS - Pre Tax Profit


Curis reported $-13.99M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 3.92B 2.35B Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
CSL USD 2.61B 1.21B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Eli Lilly USD 7.23B 456M Sep/2025
Exelixis USD 252.69M 275K Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Incyte USD 389.94M 92.37M Dec/2025
Merck USD 6.74B 22M Sep/2025
Novartis USD 4.64B 445M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Takeda JPY 133.86B 105.69B Dec/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025
Verastem USD -33.86M 6.49M Mar/2024
Xoma USD 15.98M 24.58M Jun/2024